C. Lance Cowey — ASN Events

C. Lance Cowey — ASN Events

, ,

Presentations this author is a contributor to:

Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naïve patients with advanced melanoma (MEL) (CheckMate 067) (#204)